The marketing application for AVT23, a biosimilar to the multi-billion dollar asthma drug Xolair, marks a key regulatory step for Alvotech in the European market.
The luxury carmaker has lowered its full-year forecast, citing uncertainty from US tariffs and softening global demand.
Electric scooter maker sees a 74% sales explosion in its core China market, signaling strong consumer demand.
A potent mix of positive catalysts and high short interest sends the hydrogen fuel cell company's shares soaring.
The conversational AI firm's shares surged on massive volume without a clear fundamental catalyst, pointing to a potential short squeeze or social media-driven rally.
Investor concerns over shareholder dilution intensify after the biotech company closes a $4.8 million capital raise to fund operations.
First patients implanted with the novel neurostimulator marks a key step in challenging market leader Inspire Medical after recent FDA approval.
State tech hub funding and an expanded partnership with Ember Recreational Vehicles fuel investor optimism in the battery manufacturer.